Trial · NCT03274076
Participant flow24
How many started, completed or left each group, period by period.
1 to 20 of 24
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| 24 Weeks Double Blind | STARTED | Tofacitinib Double Blind 0-24 Weeks | 10 | |
| 24 Weeks Double Blind | STARTED | Placebo Double Blind 0-24 Weeks | 5 | |
| 24 Weeks Double Blind | STARTED | Tofacitinib to Tofacitinib Open Label 24-48 Weeks | 0 | |
| 24 Weeks Double Blind | STARTED | Placebo to Tofacitinib Open Label 24-48 Weeks | 0 | |
| 24 Weeks Double Blind | COMPLETED | Tofacitinib Double Blind 0-24 Weeks | 10 | |
| 24 Weeks Double Blind | COMPLETED | Placebo Double Blind 0-24 Weeks | 4 | |
| 24 Weeks Double Blind | COMPLETED | Tofacitinib to Tofacitinib Open Label 24-48 Weeks | 0 | |
| 24 Weeks Double Blind | COMPLETED | Placebo to Tofacitinib Open Label 24-48 Weeks | 0 | |
| 24 Weeks Double Blind | NOT COMPLETED | Tofacitinib Double Blind 0-24 Weeks | 0 | |
| 24 Weeks Double Blind | NOT COMPLETED | Placebo Double Blind 0-24 Weeks | 1 | |
| 24 Weeks Double Blind | NOT COMPLETED | Tofacitinib to Tofacitinib Open Label 24-48 Weeks | 0 | |
| 24 Weeks Double Blind | NOT COMPLETED | Placebo to Tofacitinib Open Label 24-48 Weeks | 0 | |
| 24 Weeks Open Label | STARTED | Tofacitinib Double Blind 0-24 Weeks | 0 | |
| 24 Weeks Open Label | STARTED | Placebo Double Blind 0-24 Weeks | 0 | |
| 24 Weeks Open Label | STARTED | Tofacitinib to Tofacitinib Open Label 24-48 Weeks | 10 | |
| 24 Weeks Open Label | STARTED | Placebo to Tofacitinib Open Label 24-48 Weeks | 4 | |
| 24 Weeks Open Label | COMPLETED | Tofacitinib Double Blind 0-24 Weeks | 0 | |
| 24 Weeks Open Label | COMPLETED | Placebo Double Blind 0-24 Weeks | 0 | |
| 24 Weeks Open Label | COMPLETED | Tofacitinib to Tofacitinib Open Label 24-48 Weeks | 8 | |
| 24 Weeks Open Label | COMPLETED | Placebo to Tofacitinib Open Label 24-48 Weeks | 3 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03274076/flow